New in Flu

Record-Breaking: The 4-Day Pandemic Flu Vaccine

20 May 2013 / By Tim / Featured on App, Flu / 0 comments

A team of researchers for the J. Craig Venter Institute (JCVI), Synthetic Genomics Inc (SGI), Novartis Vaccines and Diagnostics, the Biomedical Advanced Research and Development [...]

 

More in Flu

• 

  Influenza Vaccines – Microneedle Patches and Antigenic Sin

  22 April 2013 / By Tim / Events, Featured on App, Flu, Prophylactic Vaccines, R&D / 0 comments

   
• 

  Influenza vaccine landscape and development

  22 April 2013 / By Tim / Events, Featured on App, Flu, Prophylactic Vaccines, R&D / 0 comments

   
• 

  IDRI and Medicago to present H5N1 vaccine data at the World Vaccine Congress

  9 April 2013 / By Tim / Featured on App, Flu, Prophylactic Vaccines, R&D / 0 comments

   
• 

  Download: Implementing Rapid Flu Vaccine Production Facing a Pandemic Threat

  8 April 2013 / By jolene / Emerging Markets, Flu, Uncategorized / 0 comments

   
• 

  WHO reports further H7N9 avian flu cases, CDC readies itself

  5 April 2013 / By Tim / Flu, Prophylactic Vaccines, R&D / 0 comments

   
• 

  Download Presentation: H5N1 & Seasonal Influenza in Indonesia

  4 April 2013 / By jolene / Emerging Markets, Flu / 0 comments

   
• 

  GlaxoSmithKline’s quadrivalent influenza vaccine approved in UK and Germany

  4 April 2013 / By Tim / Featured on App, Flu, Prophylactic Vaccines, Regulation and Policy / 0 comments

   
• 

  Guest bloggers for World Vaccine Congress Washington 2013

  26 March 2013 / By Freya Smale / Emerging Markets, Featured on App, Flu, Partnering and Corporate strategy, Prophylactic Vaccines, R&D, Regulation and Policy, Therapeutic Vaccines, Veterinary Vaccines / 0 comments

   
• 

  Flu: DNA-based Universal Vaccines – Dr Niranjan Sardesai

  12 March 2013 / By Tim / Featured Videos, Flu / 0 comments

   
• 

  Top 4 influenza vaccine FDA approvals

  1 March 2013 / By Tim / Featured on App, Flu, Prophylactic Vaccines / 1 comment